medigraphic.com
ISSN 2078-7162 (Print)

2020, Number 3

<< Back Next >>

Rev Cub de Med Fis y Rehab 2020; 12 (3)

Enteral ozone therapy: a possible safe and economical option for COVID-19 patients

Borroto RV, Jiménez TA, Dragustinovis RME

Language: Spanish
References: 44
Page:
PDF size: 481.21 Kb.


ABSTRACT

SARS-CoV-2 infection causing COVID-19 disease is a pandemic for which there are currently no specific vaccines or pharmaceutical treatments available. Ozone therapy has been proposed to treat this disease. The literature available from 2000 to 2020 was reviewed, with the aim of identifying preclinical and clinical reviews and studies that provide information on the biological and therapeutic effects of systemic administration of ozone by enteral rectal insufflation, which could be useful in the different phases, stages and degrees of severity of this disease, as well as in the prevention and rehabilitation of possible sequelae. The Google Academic search engine was used and articles from the PubMed and SciELO databases of the Virtual Health Library were consulted. Information was found that indicates that the rectal application of ozone has biological and therapeutic actions that could be useful to treat COVID-19 in two clinical phases, in the degrees of mild, moderate and severe severity. As well as for the prevention and rehabilitation of possible sequels. It could also be used to treat patients with high risk factors who are exposed to this infection.


REFERENCES

  1. Mizumoto K, Chowell G. Transmission potential of the novel coronavirus (COVID-19) onboard the diamond Princess Cruises Ship, 2020. Infectious disease modelling 2020 [acceso: 05/05/2020]; 5:264- 70. DOI: https://doi.org/10.1016/j.idm.2020.02.003

  2. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)-China. 2020. China CDC Weekly. 2020 [acceso: 16/03/2020]. Disponible en: http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51

  3. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 [acceso: 07/02/2020].

  4. Organización Mundial de la Salud (2020). Manejo clínico de la infección respiratoria aguda grave (IRAG) en caso de sospecha de COVID-19: orientaciones provisionales. 2020 [acceso: 04/05/2020]. Disponible en: https://apps.who.int/iris/handle/10665/331660. License: CC BY-NC-SA 3.0 IGO

  5. Centro de Estudios de Población y Desarrollo. Envejecimiento de la población cubana. Cuba y sus territorios (2018) de la Oficina Nacional de Estadística e Información (ONEI). 2018 [acceso: 05/05/2020]. Disponible en: https://www.cubahora.cu/sociedad/cuba-poblacion-de-60-anos-y-mas-parte-ii-mapa

  6. Gauna ME, Bernava JL. Recomendaciones diagnósticas y terapéuticas ante la respuesta inmune trombótica asociada a COVID-19 (RITAC). 2020 CorSalud [acceso: 10/04/2020]; [S.l.] 12(1):60-3. ISSN 2078-7170. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/615/1110

  7. Rowen RJ, Robins H (2020) A Plausible “Penny” Costing Effective Treatment for Corona Virus- Ozone Therapy. J Infect Dis Epidemiol 6:113. DOI: https://doi.org/10.23937/2474-3658/1510113

  8. ISCO3. ISCO3/EPI/00/04. El uso potencial de ozono en SARS-CoV-2/COVID-19. Madrid, 2020. Comité Científico Internacional de Ozonoterapia [acceso: 07/04/2020]. Disponible en: www.isco3.org

  9. Hernández A, Baeza J. Dos terapias conocidas podrían ser efectivas como adyuvantes en el paciente crítico infectado por COVID-19. Rev Esp Anestesiol Reanim. 2020. DOI: https://doi.org/10.1016/j.redar.2020.03.004

  10. Martínez-Sánchez G, Shhwartz A, Di Donnaa V. Potencial Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19. Antioxidants 2020. [acceso: 05/05/2020]; 9(389). DOI: https://doi.org/10.3390/antiox9050389

  11. Hernández A, Viñals M, Pablos A, Vilas F, Papadakos PJ, Wijeysundera DN, Vives M. Ozone therapy for patients with SARS-COV-2 pneumonia: a singlecenter prospective cohort study. medRxiv preprint. DOI: https://doi.org/10.1101/2020.06.03.20117994

  12. ISCO3. ISCO3/MET/00/23 Rectal Insuffation. Ed. Borroto-Rodríguez, Vivian and Martínez-Sánchez G. 2017 [acceso: 05/06/2020]; 9. Disponible en: https://isco3.org/officialdocs

  13. Borroto Rodríguez V, Lima Hernández LB, Cambara Peña R. (2010) Resultados y proyecciones del Centro Nacional de Medicina Natural y Tradicional para la extensión de la ozonoterapia a la atención primaria de salud y servicios de oncología en el sistema nacional de salud. Contribuciones al desarrollo de la hidrología médica, Medicina Natural y Tradicional. Centro Nacional de Medicina Natural y Tradicional (Primera Edición) GEOTECH, La Habana, 26 pp. ISBN 959-7167-21-2.

  14. Hasan K, Siddiqi MD, MSCR, Mandeep R, Mehra MD. COVID-19 illness in native and immunosuppressed states: A Clinical-Therapeutic Staging Proposal, Journal of Heart and Lung Transplantation (2020) [acceso: 26/04/2020]. DOI: https://doi.org/10.1016/j.healun.2020.03.012

  15. Mehta P, McAuley DF, Brown M, Sánchez E, Tat-tersall RS, Manson JJ. COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression. Lancet. 2020; 395(10229):1033-4.

  16. López PGT, Ramírez SMLP, Torres AMS. Participantes de la respuesta inmunológica ante la infección por SARS-CoV-2. Alerg Asma Inmunol Pediatr. 2020 [acceso: 05/06/2020]; 29(1):5-15. DOI: https://doi.org/10.35366/9332

  17. Ahmadpoor P, Rostaing L. Why the immune system fails to mount an adaptive immune response to a COVID-19 infection. Transplant International. 2020 [acceso: 25/04/2020]. DOI: https://doi.org/10.1111/tri.13611

  18. Abdulamir AS, Hafidh RR. The Possible Immunological Pathways for the Variable Immunopathogenesis of COVID-19 Infections among Healthy Adults, Elderly and Children. Electron J Gen Med. 2020 [acceso: 25/04/2020]; 17(4): em202. DOI: https://doi.org/10.29333/ejgm/7850

  19. Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA, 2016; 35(8):801-10. Disponible en: https://www.mendeley.com/catalogue/third-international-consensusdefinitions-sepsis-septic-shock-sepsis3

  20. Levi M, van der Poll T (2017). Coagulation and sepsis. Thromb Res 149:38-44.

  21. Schmitt FCF, Manolov V, Morgenstern J. Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study. Ann Intensive Care. 2019; 9(1):19.

  22. Gupta N, Zhao YY, Evans CE. The stimulation of thrombosis by hypoxia. Thromb Res. 2019:181:77-83.

  23. Shiyu Yin, Ming Huang, Dengju Li, Ning Tang. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. Journal of Thrombosis and Thrombolysis https://doi.org/10.1007/s11239-020-02105-8

  24. Aubourg P. (1936). Colibacillose aigue, colibacillose cronique: ameliorations cliniques notables par un traitement d’ozone. Bull. Med. Paris; 140:644-54.

  25. ISCO3/QAU/01/03. Declaración de Madrid sobre la ozonoterapia 2015-2020. Schwartz-Tapia A, Martínez-Sánchez G, Sabah F, Alvarado-Guémez F, Bazzano-Mastrelli N, Bikina O, Borroto-Rodríguez V, Cakir R, Clavo B, González-Sánchez E, Grechkanev G, Najm Dawood AH, Izzo A, Konrad H, Masini M, Peretiagyn S, Pereyra, VR, Ruiz Reyes D, Shallenberger F, Vongay V, Xirezhati A, Quintero-Marino, R. Declaración de Madrid sobre la terapia con ozono. 2ª ed. Madrid: ISCO3; ISBN 978-84-606-8312-4; 2015. 50 pp. Disponible en: https://isco3.org/officialdocs/

  26. Viebahn-Hänsler R, Fernández O, Fahmy Z. Ozone in Medicine: Clinical Evaluation and Evidence Classification of the Systemic Ozone Applications, Major Autohemotherapy and Rectal Insufflation, According to the Requirements for Evidence-Based Medicine. Ozone: Science & Engineering. 2016. 38(5) 322-45.

  27. Menéndez-Cepero SA, Zamora Z, Hernández F. Importance of the Toxicological Tests in the Application and Safety of Ozone Therapy, J Ozone Ther. 2018:2(3). DOI: https://doi.org/10.7203/jo3t.2.3.2018.10009

  28. Pecorelli, Alessandra & Bocci, Velio & Acquaviva, Alessandra & Belmonte, Giuseppe & Gardi, Concetta & Virgili, Fabio & Ciccoli, Lucia & Valacchi, Giuseppe. NRF2 Activation is involved in Ozonated Human Serum Upregulation of HO-1 in Endothelial Cells. Toxicology and applied pharmacology. 267-2012. Disponible en: https://doi.org/10.1016/j.taap.2012.12.001

  29. Díaz Luis J, Macías Abraham C, Menéndez Cepero S. Efecto modulador de la ozonoterapia sobre la actividad del sistema inmune. Rev Cubana Hematol Inmunol Hemoter. 2013 [acceso: 06/06/2020]; 29(2): 143-53. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892013000200005&lng=es

  30. Seda Artis A, Aydogan S, Gokhan Sahin M. The Effects of Colorectally Insufflated Oxygen-ozone on Red Blood Cell Rheology in Rabbits. 2010: 329-36.

  31. Zamora Rodríguez, Borrego Álvarez. La mezcla gaseosa ozono-oxígeno incrementa la respuesta humoral contra el antígeno recombinante de superficie del virus de la hepatitis B en ratones. Revista CENIC Ciencias Biológicas. 2002; 33(2)55-7.

  32. Calunga JL, Menéndez S, Zamora Z. Ozonetheray on rats submitted to subtotal nephrectomy: role of interleukin 6 and antioxiden System. Revista Cubana de Investigaciones Biomédicas. 2019,38(1).

  33. Díaz J, Sardiñas G, Menéndez S, Macías C. Efecto inmunomodulador de la ozonoterapia en niños con deficiencia en la inmunidad mediada por fagocitos. Mediciego 2012;18(1). Disponible en: http://bvs.sld.cu/revistas/mciego/vol18_01_2012/articulos/t -9.html

  34. León Fernández OS, Takon Oru G, López Cabreja GM, Serrano Espinosa I, García Fernández E. Gamma glutamil transferasa, un marcador de la eficacia clínica del ozono médico y su rol patológico en la artritis reumatoide y la osteoartritis de rodilla. Rev Cubana de Reumatolo. 2020 [acceso: 06/06/2020]; 22(1). Disponible en: http://www.revreumatologia.sld.cu/index.php/reumatologia/article/view/756

  35. Díaz-Luis J, Menéndez-Cepero S, Macías-Abraham C, Fariñas-Rodríguez L. Systemic Ozone Therapy by Rectal Insufflation for Immunoglobulin A Deficiency. MEDICC Review, January 2018: 20(1).

  36. Wilkins-Perez: Ozone and Cardiovascular Diseases in Elderly Patients. Oxid Antioxid Med Sci. 2015; 4: 23-7. DOI: https://doi.org/10.5455/oams. 250115.or.080

  37. Delgado-Roche L, Riera-Romo M, Mesta F, Hernández-Matos Y, Barrios JM, Martínez-Sánchez G, Al-Dalaien SM. Medical ozone promotes Nrf2 phosphorylation reducing oxidative stress and pro-inflammatory cytokines in multiple sclerosis patients. Eur J Pharmacol. 2017 Sep 15; 811:148-54. DOI: https://doi.org/10.1016/j.ejphar.2017.06.017

  38. Calunga JL, Paz AY, Menéndez CS, Martínez A, Hernández A. Rectal ozone therapy for patients with pulmonary emphysema. Rev Med Chile 2011; 139:439-47.

  39. Borroto V, Lima LB, Lima S, Marín M, Castellanos JC, Cambara R. (2013) Prevención del ictus con la aplicación de ozonoterapia. Revista Cubana de Medicina Física y Rehabilitación; 5(1).

  40. Baeza Noci J, Cabo Soler JR, Gómez Moraleda M, Menéndez Cepero S, Re Lamberto. (2015) WFOT’s Review on Evidence Based Ozone Therapy© World Federation of Ozone Therapy–WFOT [acceso: 08/06/2020]. Disponible en: https://asociatia-ozonoterapie.ro/evidence-based-ozone-therapy-wfot-review

  41. Martínez-Sánchez G, Menéndez-Cepero S, Copello M, Díaz-Llera S; Re L. (2012). Rectal insufflations are a valid way in ozonetherapy. Revista Española de Ozonoterapia. 2(1)233-5.

  42. Bocci V, Valacchi G. Nrf2 activation as target to implement therapeutic treatments. Front Chem. 2015;3:4. DOI: https://doi.org/10.3389/fchem.2015.00004; PMID: 25699252; PMCID: PMC4313773.

  43. Bocci V, Borrelli E, Corradeschi F, Valacchi G. Efectos sistémicos después de la insuflación colorrectal de oxígeno-ozono en conejos. Int J Med Biol Environ. 2000; 28:109-13 [Google Scholar].

  44. Bocci V, Zanardi I, and Travagli V. Ozone acting on human blood yields a hormetic dose-response relationship. J. Transl. Med. 2011, 9:66-77. DOI: https://doi.org/10.1186/1479-5876-9-66.




2020     |     www.medigraphic.com